Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07124065) titled 'Differentiation of Benign From Malignant Thyroid Nodules Using Diffuse Reflectance Spectroscopy' on Aug. 8.

Study Type: Observational

Primary Sponsor: Imperial College London

Condition: Thyroid Cancer Nodule Solitary Thyroid

Intervention: Diagnostic Test: Diffuse reflectance spectroscopy

Recruitment Status: Not recruiting

Date of First Enrollment: March 20, 2024

Target Sample Size: 50

Countries of Recruitment: United Kingdom

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07124065

Published by HT Digital Content Services with permission from Health Daily Digest....